How common is Prostate cancer?

Teerera peji iri

Kenza yeprostate yakajairika zvakadini?

Kenza yeprostate ndeimwe yemhando dzakajairika dzegomarara muvarume, zvikurukuru muvarume vakwegura.

Maererano neAmerican Cancer Society, kenza yeprostate ndiyo kenza yechipiri yakajairika muvarume vokuAmerica, shure kwekenza yeganda.

MuUnited States, anenge murume mumwe pavarume vapfumbamwe achabatwa nekenza yeprostate muupenyu hwake.

Muna 2021, zvinofungidzirwa kuti kuchava nevanhu vanenge 248,530 vachange vachirwara nekenza yeprostate uye vanenge 34,130 vachafa nekenza yeprostate.

Zvisinei, zvinokosha kucherechedza kuti kenza yeprostate inogona kurapwa zvikuru, uye mwero wokupona wakakwirira apo inoonekwa nokukurumidza.

Mashoko okufananidzira

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Fesinmeyer MD, Gulati R, Zeliadt S, Weiss N, Kristal AR, Etzioni R: Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States. Cancer Epidemiol Biomarkers Prev. 2009, 18 (3): 808-15.

Peng P, Gong YM, Bao PP, Ke JZ, Xiang YM, Zhang ML, Zheng Y: [Estimates and prediction of prostate cancer incidence, mortality and prevalence in China, 2008]. Zhonghua Liu Xing Bing Xue Za Zhi. 2012, 33 (10): 1056-9.

Delongchamps NB, Singh A, Haas GP: The role of prevalence in the diagnosis of prostate cancer. Cancer Control. 2006, 13 (3): 158-68.

Li J, German R, King J, Joseph D, Thompson T, Wu XC, Ajani U, Tai E: Recent trends in prostate cancer testing and incidence among men under age of 50. Cancer Epidemiol. 2012, 36 (2): 122-7.

Yu XQ, Luo Q, Smith DP, Clements MS, O'Connell DL: Prostate cancer prevalence in New South Wales Australia: a population-based study. Cancer Epidemiol. 2015, 39 (1): 29-36.

Ondrusova M, Mrozova L, Ondrus D, Mrinakova B: Trends and estimates in prostate cancer incidence, mortality and prevalence in the Slovak Republic, 1968-2012. Neoplasma. 2013, 60 (4): 446-51.

Kurambidzwa kwebasa: zvokurapa

Nzvimbo iyi yepaIndaneti inopiwa nokuda kwezvinangwa zvedzidzo uye zvemashoko chete uye haisi kupa mazano ezvokurapa kana kuti mabasa ehunyanzvi.

Mashoko anopiwa haafaniri kushandiswa kuongorora kana kuti kurapa chinetso cheutano kana kuti chirwere, uye avo vanotsvaka mazano ezvokurapa vanofanira kubvunza chiremba ane rezinesi.

Ndapota cherechedzai kuti neural net iyo inogadzira mhinduro dzemibvunzo, haina kururama zvikuru kana iri nyaya yenhamba. Somuenzaniso, nhamba yevanhu vanoonekwa vaine chirwere chakati.

Nguva dzose tsvaka zano rachiremba wako kana mumwe mupi wezvoutano akakodzera pamusoro pemamiriro ezvinhu ezvokurapa. Usambofa wakaregeredza zano rezvokurapa rehunyanzvi kana kunonoka kuritsvaka nemhaka yechinhu chipi nechipi chawakaverenga pawebsite ino. Kana uchifunga kuti unogona kuva nenjodzi yezvokurapa, fonera 911 kana kuenda kukamuri rokukurumidzira riri pedyo nokukurumidza. Hapana ukama hwechiremba nemurwere hunogadzirwa newebhusaiti ino kana kushandiswa kwayo. NeBioMedLib kana vashandi vayo, kana chero mupiro kune iyi webhusaiti, haitauri chero zvirevo, zvakataurwa kana kuti zvataurwa, maererano neruzivo rwunopihwa pano kana kushandiswa kwayo.

Kurega mutoro: kodzero dzekunyora

Digital Millennium Copyright Act ya1998, 17 U.S.C. § 512 (iyo DMCA) inopa nzira yekutsvaga varidzi vemvumo vanotenda kuti zvinhu zvinoonekwa paInternet zvinotyora kodzero dzavo pasi pemutemo wekodzero dzeUS.

Kana iwe uchidavira mukutenda kwakanaka kuti chero zvemukati kana zvinhu zvakaitwa kuti zviwanikwe zvine chekuita newebhusaiti yedu kana masevhisi zvinotyora kodzero dzako, iwe (kana mumiririri wako) unogona kutitumira chiziviso chinokumbira kuti zvemukati kana zvinhu zvibviswe, kana kuwana kwazviri kuvharirwa.

Zviziviso zvinofanira kutumirwa zvakanyorwa neemail (ona chikamu che"Kubata" kuti uwane kero yeemail).

DMCA inoda kuti chiziviso chako chekutyora kwekodzero dzekodzero dzekodzero zvinosanganisira ruzivo runotevera: (1) tsananguro yebasa rine kodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero.

(5) chirevo chako, chakasainwa pasi pechirango chehupombwe, chokuti mashoko ari mukuziviswa ndeechokwadi uye kuti une simba rokumanikidza kodzero dzevanyori dzinonzi dzakaputsika;

uye (6) siginicha yepanyama kana yemagetsi yemuridzi wekodzero kana munhu ane mvumo yekuita muzita remuridzi wekodzero.

Kukundikana kuisa mashoko ose ari pamusoro apa kungaguma nokunonoka kugadziriswa kwekunyunyuta kwako.

Kutaurirana

Ndapota titumirei email nemibvunzo ipi neipi / mazano.

How common is prostate cancer?

Prostate cancer is one of the most common types of cancer in men, particularly in older men.

According to the American Cancer Society, prostate cancer is the second most common cancer in American men, behind skin cancer.

In the United States, about 1 in 9 men will be diagnosed with prostate cancer during their lifetime.

In 2021, it is estimated that there will be about 248,530 new cases of prostate cancer and about 34,130 deaths from prostate cancer.

However, it is important to note that prostate cancer is highly treatable, and the survival rate is high when it is detected early.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.